Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278212 · ClinicalTrials.gov registry record · NA
Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT01278212: Completed NA study, sponsored by University of Louisville.
NCT01278212 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 158 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01278212, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The goal of this study is to explore the safety, effectiveness, quality of life, and cost effectiveness of accelerated hypofractionated radiotherapy (AHF-RT) as treatment after lumpectomy in patients with early stage breast cancer.
Primary Outcome
Both invasive and non-invasive IBTRs will be considered in calculating the primary endpoint.
Interventions
- RADIATION accelerated hypofractionated radiotherapy (AHF-RT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2011-01 |
| Est. Completion | 2021-01-27 |
| Phase | NA |
What the finished NCT01278212 record still lists
NCT01278212 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which accelerated hypofractionated radiotherapy (AHF-RT) is the first listed.
NCT01278212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01278212 about?
NCT01278212 is a clinical study titled "Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer". The goal of this study is to explore the safety, effectiveness, quality of life, and cost effectiveness of accelerated hypofractionated radiotherapy (AHF-RT) as treatment after lumpectomy in patients with early stage breast cancer.
What is the current status of trial NCT01278212?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2011-01. Estimated completion is 2021-01-27.
What interventions are being tested in trial NCT01278212?
The interventions under investigation include: accelerated hypofractionated radiotherapy (AHF-RT) (RADIATION).
Who is sponsoring clinical trial NCT01278212?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01278212's enrollment target sits among peer trials
158 654th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia